Celsius (CELH) to Release Earnings on Wednesday

Key Points

• Celsius Holdings will release its Q3 2025 earnings report on November 5, 2025, with analysts predicting earnings of $0.26 per share and revenue of approximately $703.68 million.
• The company's previous earnings report revealed a significant 83.9% year-over-year revenue increase, with earnings per share beating estimates by $0.24 at $0.47.
• JPMorgan Chase increased its target price for Celsius from $68.00 to $76.00, indicating a positive outlook for the stock with multiple analysts rating it as a "Buy."

Celsius (NASDAQ:CELH - Get Free Report) is anticipated to post its Q3 2025 results before the market opens on Wednesday, November 5th. Analysts expect Celsius to post earnings of $0.26 per share and revenue of $703.6770 million for the quarter. Individuals may review the information on the company's upcoming Q3 2025 earningreport for the latest details on the call scheduled for Wednesday, November 5, 2025 at 8:00 AM ET.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. The company had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The company's quarterly revenue was up 83.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.28 earnings per share. On average, analysts expect Celsius to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Celsius Stock Down 0.5%

NASDAQ CELH opened at $61.90 on Wednesday. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock's 50 day moving average is $59.31 and its two-hundred day moving average is $48.33. The company has a market capitalization of $15.97 billion, a price-to-earnings ratio of 167.30, a PEG ratio of 1.26 and a beta of 1.38. Celsius has a 1-year low of $21.10 and a 1-year high of $66.74.

Insider Activity

In other Celsius news, insider Paul H. Storey sold 7,500 shares of the company's stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $60.93, for a total transaction of $456,975.00. Following the transaction, the insider owned 37,550 shares of the company's stock, valued at approximately $2,287,921.50. This represents a 16.65% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Deborah Desantis sold 100,000 shares of the company's stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $47.50, for a total value of $4,750,000.00. Following the transaction, the insider directly owned 17,717,770 shares in the company, valued at approximately $841,594,075. This represents a 0.56% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 405,667 shares of company stock worth $20,665,162. 2.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Captrust Financial Advisors lifted its stake in shares of Celsius by 90.9% in the 2nd quarter. Captrust Financial Advisors now owns 12,713 shares of the company's stock valued at $590,000 after purchasing an additional 6,052 shares during the period. Blue Chip Partners LLC increased its position in shares of Celsius by 2.4% in the 2nd quarter. Blue Chip Partners LLC now owns 11,701 shares of the company's stock valued at $543,000 after buying an additional 271 shares in the last quarter. Oxford Asset Management LLP bought a new stake in shares of Celsius in the 2nd quarter valued at $492,000. Nomura Holdings Inc. bought a new stake in shares of Celsius in the 2nd quarter valued at $448,000. Finally, Occudo Quantitative Strategies LP bought a new stake in shares of Celsius in the 2nd quarter valued at $394,000. Institutional investors and hedge funds own 60.95% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. JPMorgan Chase & Co. boosted their target price on Celsius from $68.00 to $76.00 and gave the stock an "overweight" rating in a report on Friday, October 24th. Cowen reissued a "buy" rating on shares of Celsius in a report on Tuesday, September 2nd. Roth Capital reissued a "buy" rating on shares of Celsius in a report on Thursday, October 2nd. Piper Sandler boosted their target price on Celsius from $60.00 to $69.00 and gave the stock an "overweight" rating in a report on Monday, September 8th. Finally, Maxim Group boosted their target price on Celsius from $50.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Nineteen research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $64.45.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.